UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 42

Sortiert nach

Pharmacovigilance And Risk Management: How to Detect, Evaluate and Minimize The Risks: A European Point of View

Clinical therapeutics, 2015-08, Vol.37 (8), p.e166-e166

Le Louet, H

2015

Volltextzugriff (PDF)

A Call to Incorporate Systems-Theoretic Advances and Human Factors into Our Existing Investigations of Harm in Human Clinical Research Involving Healthcare Products

Clinical therapeutics, 2017-08, Vol.39 (8), p.e103-e104

2017

Volltextzugriff (PDF)

ALDEN, an Algorithm for Assessment of Drug Causality in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Comparison With Case-Control Analysis

Clinical pharmacology and therapeutics, 2010-07, Vol.88 (1), p.60-68

2010

Volltextzugriff (PDF)

Melanoma during latanoprost therapy: three cases

Annales de dermatologie et de vénéréologie, 2009-01, Vol.136 (1), p.60

2009

Volltextzugriff (PDF)

Mélanomes associés au latanoprost : trois cas

Annales de dermatologie et de vénéréologie, 2009, Vol.136 (1), p.60-61

2009

Volltextzugriff (PDF)

Analysis of the direct cost of adverse drug reactions in hospitalised patients

European journal of clinical pharmacology, 2001-03, Vol.56 (12), p.935-941

2001

Volltextzugriff (PDF)

DRESS: is oxcarbazepine safer than carbamazepine? An analysis of the French Pharmacovigilance database

European journal of neurology, 2008-05, Vol.15 (5), p.e43-e43

2008

Volltextzugriff (PDF)

Advancing Drug Safety Through Prospective Pharmacovigilance

Therapeutic innovation & regulatory science, 2018-07, Vol.52 (4), p.400-402

2018

Volltextzugriff (PDF)

Guiding principles for the use of knowledge bases and real-world data in clinical decision support systems: report by an international expert workshop at Karolinska Institutet

Expert review of clinical pharmacology, 2020-09, Vol.13 (9), p.925-934

2020

Volltextzugriff (PDF)

Systemic antifungal agents : Drug interactions of clinical significance

Drug safety, 1998-02, Vol.18 (2), p.83-97

1998

Volltextzugriff (PDF)

DRESS: Is Oxcarbazepine Safer than Carbamazepine?

Drug safety, 2007, Vol.30 (10), p.919-990

2007

Volltextzugriff (PDF)

Immunosuppressive drugs and pregnancy: Experimental and clinical data

Transplantation proceedings, 1997-08, Vol.29 (5), p.2461-2466

1997

Volltextzugriff (PDF)

Pharmacovigilance and Clinical Trials: Experience of a French Pharmacovigilance Department

Drug safety, 2007, Vol.30 (10), p.919-990

2007

Volltextzugriff (PDF)

Méthodes de surveillance et de gestion des risques des médicaments pour la future mère, l’embryon, le fœtus et le nouveau-né

Therapie, 2006-07, Vol.61 (4), p.287-295

2006

Volltextzugriff (PDF)

Medication Errors Management Process in AP-HP Hospitals

Drug safety, 2007, Vol.30 (10), p.919-990

2007

Volltextzugriff (PDF)

Comparison of Adverse Drug Reactions with Donepezil versus Memantine: Analysis of the French Pharmacovigilance Database

Therapie, 2010-05, Vol.65 (3), p.255-259

2010

Volltextzugriff (PDF)

Attenuation of liver normothermic ischemia-reperfusion injury by preservation of mitochondrial functions with S-15176, a potent trimetazidine derivative

Biochemical pharmacology, 2001-08, Vol.62 (4), p.509-516

2001

Volltextzugriff (PDF)

Medication Errors Management in Hospital: Three-Month Results

Drug safety, 2008, Vol.31 (10), p.885-885

2008

Volltextzugriff (PDF)

Le statut d'acétylation n'influence pas la réponse à la dapsone dans le purpura thrombopénique auto-immun de l'adulte

La revue de medecine interne, 1999-06, Vol.20, p.s40-s40

1999

Volltextzugriff (PDF)

Lack of relevance of the acetylator status on dapsone response in chronic autoimmune thrombocytopenic purpura

American journal of hematology, 1999-12, Vol.62 (4), p.251-252

1999

Volltextzugriff (PDF)

Inhibition of mitochondrial carnitine palmitoyltransferase-1 by a trimetazidine derivative, S-15176

Pharmacological research, 2001-08, Vol.44 (2), p.99-104

2001

Volltextzugriff (PDF)

Low glucocorticoid concentrations decrease oxidative phosphorylation of isolated rat brain mitochondria: an additional effect of dexamethasone

Fundamental & clinical pharmacology, 2000-09, Vol.14 (5), p.493-500

2000

Volltextzugriff (PDF)

Development of diffuse psoriasis with alopecia during treatment of Crohn's disease with infliximab

Gastroentérologie clinique et biologique, 2010-02, Vol.34 (2), p.140-141

2010

Volltextzugriff (PDF)

S15176 and S16950 interaction with Cyclosporin A antiproliferative effect on cultured human lymphocytes

Fundamental & clinical pharmacology, 2001-02, Vol.15 (1), p.41-46

2001

Volltextzugriff (PDF)

Trimetazidine: Experimental and Clinical Update Review

Cardiovascular drug reviews, 1998-12, Vol.16 (4), p.359-390

1998

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(40)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(23)
Science & Technology
(23)
Humans
(18)
Pharmacology & Pharmacy
(14)
Male
(12)
Female
(11)
Biological And Medical Sciences
(10)
Medical Sciences
(10)
Pharmacology. Drug Treatments
(9)
Adult
(7)
Pharmacovigilance
(7)
Middle Aged
(5)
Drug Interactions
(4)
Aged, 80 And Over
(3)
Animals
(3)
Antioxidants - Pharmacology
(3)
Dermatology
(3)
Drug Safety And Pharmacovigilance
(3)
Drug-Related Side Effects And Adverse Reactions
(3)
France - Epidemiology
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pharmacovigilance And Risk Management: How to Detect, Evaluate and Minimize The Risks: A European Point of View

A Call to Incorporate Systems-Theoretic Advances and Human Factors into Our Existing Investigations of Harm in Human Clinical Research Involving Healthcare Products

ALDEN, an Algorithm for Assessment of Drug Causality in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Comparison With Case-Control Analysis

Melanoma during latanoprost therapy: three cases

Mélanomes associés au latanoprost : trois cas

Analysis of the direct cost of adverse drug reactions in hospitalised patients

DRESS: is oxcarbazepine safer than carbamazepine? An analysis of the French Pharmacovigilance database

Advancing Drug Safety Through Prospective Pharmacovigilance

Guiding principles for the use of knowledge bases and real-world data in clinical decision support systems: report by an international expert workshop at Karolinska Institutet

Systemic antifungal agents : Drug interactions of clinical significance

DRESS: Is Oxcarbazepine Safer than Carbamazepine?

Immunosuppressive drugs and pregnancy: Experimental and clinical data

Pharmacovigilance and Clinical Trials: Experience of a French Pharmacovigilance Department

Méthodes de surveillance et de gestion des risques des médicaments pour la future mère, l’embryon, le fœtus et le nouveau-né

Medication Errors Management Process in AP-HP Hospitals

Comparison of Adverse Drug Reactions with Donepezil versus Memantine: Analysis of the French Pharmacovigilance Database

Attenuation of liver normothermic ischemia-reperfusion injury by preservation of mitochondrial functions with S-15176, a potent trimetazidine derivative

Medication Errors Management in Hospital: Three-Month Results

Le statut d'acétylation n'influence pas la réponse à la dapsone dans le purpura thrombopénique auto-immun de l'adulte

Lack of relevance of the acetylator status on dapsone response in chronic autoimmune thrombocytopenic purpura

Inhibition of mitochondrial carnitine palmitoyltransferase-1 by a trimetazidine derivative, S-15176

Low glucocorticoid concentrations decrease oxidative phosphorylation of isolated rat brain mitochondria: an additional effect of dexamethasone

Development of diffuse psoriasis with alopecia during treatment of Crohn's disease with infliximab

S15176 and S16950 interaction with Cyclosporin A antiproliferative effect on cultured human lymphocytes

Trimetazidine: Experimental and Clinical Update Review

Suchergebnisse filtern